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Introduction
Malaysia is a tropical rainforest country and 
stores the most biologically diverse environment 
in the world (Lee and Houghton, 2005). The huge 
diversity of the Malaysian forest means that we 
can expect well diverse chemical structure from 
their secondary metabolite and chemical diversity 
for searching the new agent or novel drug which 
suite with the current demand particularly in curing 
various chronic diseases. It is believed that forest 
dwellers in Southeast Asia particularly in Malaysia 
use 6,500 different plants to treat illness. These same 
rain forests have supplied the western world with 
herbs and spices for centuries. 
Damnacanthal and nordamnacanthal 
comprise a general class of athraquinone 
derivatives. Damnacanthal or 3-hydroxy-1-
me thoxyan th raqu inone -2 -ca rboxa ldehyde 
(C16H10O5), occurs as pale yellow crystals with a 
melting point of 210-211°C whereas nordamnacanthal 
or 2-formyl-1,3-dihydroxyanthraquinone (C15H8O5), 
are orange yellow crystals with melting point of 214-
218°C.  Both these naturally occurring quinone are 
present widely in the Morinda species. Damnacanthal 
and nordamnacanthal have some unique chemical 
and biological properties. Ali et al. (2000) reported 
that damnacanthal and nordamnacanthal isolated 
from M. elliptica were cytotoxic towards the MCF-7 
(breast carcinoma) and CEM-SS (T-lymphoblastic 
leukemia) cell lines. 
Zerumbone is a monocyclic sesquiterpene can 
be found abundantly in rhizomes particularly from 
Zingiber zerumbet Smith and Zingiber aromaticum 
(Murakami et al., 2002). Its molecular formula 
is C15H22O. Zerumbone is a food phytochemical 
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Abstract: The present study was to evaluate the toxicity of damnacanthal, nordamnacanthal, betulinic acid and 
zerumbone isolated from local medicinal plants towards leukemia cell lines and immune cells by using MTT 
assay and flow cytometry cell cycle analysis. The results showed that damnacanthal significantly inhibited HL-
60 cells, CEM-SS and WEHI-3B with the IC50 value of 4.0 µg/mL, 8.0 µg/mL and 3.3 µg/mL, respectively. 
Nordamnacanthal and betulinic acid showed stronger inhibition towards CEM-SS and HL-60 cells with the 
IC50 value of 5.7 µg/mL and 5.0 µg/mL, respectively. In contrast, Zerumbone was demonstrated to be more 
toxic towards those leukemia cells with the IC50 value less than 10 µg/mL. Damnacanthal, nordamnacanthal 
and betulinic acid were not toxic towards 3T3 and PBMC compared to doxorubicin which showed toxicity 
effects towards 3T3 and PBMC with the IC50 value of 3.0 µg/mL and 28.0 µg/mL, respectively. The cell cycle 
analysis exhibited that damnacanthal exerted its toxicity effect towards HL-60 cells by inducing apoptosis with 
value of 25% after 72 hours treatment. Thus, these compounds could be the potential anticancer drug with less 
toxic side effect.
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possessing great potential for use in chemoprevention 
and chemotherapy strategies against cancers. 
Based on the extensive research done previously, 
zerumbone has shown very potent anticancer and 
antitumor activity. Takada et al. (2005) found that 
zerumbone suppressed the activation NF-KappaB 
and NF-KappaB-regulated gene expression induced 
by carcinogens, and reported that this inhibition 
may provide molecular basis for the prevention 
and treatment of cancer. In the same year as well, 
Huang et al. (2005) identified that zerumbone 
inhibited the growth of P-388D cells and induced 
DNA fragmentation in culture and significantly 
prolonged the life of P-388D(1)-bearing CDF(1) 
mice. Furthermore, it also inhibited the growth of 
human leukemia cell line (HL-60 cell) and human 
colon cancer (HT-29) in vitro (Kirana et al., 2003). 
Betulinic acid [3β-hydroxy-lup-20(19) lupean-
28-carbonic acid] is a lupine-type triterpene which 
was first isolated in 1948 from bark of the London 
plane tree (Platanus acerifolia) (Jung and Duclos, 
2006). It can be found abundantly in the bark of the 
white birch (Betula alba) or can also be chemically 
derived from betulin (Rene et al., 2006). Betulin 
is an abundant naturally occurring triterpene and it 
is found predominantly in bushes and trees. Both 
betulin and betulinic acid possess a wide spectrum 
of biological and pharmacological activities (Sami et 
al., 2006). Betulinic acid and its derivatives showed 
cytotoxicity against variety of tumor and cancer cell 
lines comparable to some clinically used drug. For 
instant, Jeremias et al. (2004) found that in vitro 
betulinic acid induced specific cell death of more 
than 75% in primary glioblastoma multiforme cells 
at substantially higher rate than established cytotoxic 
drugs vincristine. When betulinic acid was compared 
for in vitro efficiency against several leukemia cell 
lines with conventionally used cytotoxic drugs, 
betulinic acid was more active than 9 out of standard 
therapeutic such as L-asparaginase, dexamethasone, 
prednisolone and 6-thioguanine (Ehrhardt et al., 
2004). 
Although the cytotoxicity of these compounds 
which derived from local plant source has been 
studied intensively, they have not been tested and 
compared yet. Besides, the effect of the compounds 
on the cell cycle progression of HL60 also not been 
fully discovered yet. Thus, this study was carried out 
to investigate the cytotoxicity of these compounds 
and their effect towards the cell cycle progression of 
HL60. 
Materials and Methods
Cells
The cancerous and non-cancerous cell lines 
(suspension and anchorage-dependent cells) 
were obtained from the American Type Culture 
Collection (ATCC), the National Cancer Institute 
(NCI) and the RIKEN Cell Bank (RCB). The 
cancerous cell lines used were CEM-SS (Human 
T-lymphoblastic leukemia) (RCB), HL-60 (Human 
acute promyelocytic leukemia) (ATCC) and WEHI-
3B (Mouse myelomonocyte leukemia) (NCI). The 
non-cancerous cell line and normal cells were 3T3 
(Mouse embryo fibroblast) (ATCC) and human 
peripheral blood mononuclear cells (PBMC). PBMC 
were kindly supplied by Mr. Yeap Swee Keong, 
Mr. Teo Guan Young, Ms. Haszalina Md. Isa and 
Ms. Rohaya Ibrahim from Institute of Biosciences 
and Faculty of Biotechnology and Biomolecular 
Sciences, UPM. Blood (20-25mL) was taken from 
four donors by using the 25 mL syringe. The blood 
sample was diluted with same volume of PBS. After 
that, the diluted blood sample was carefully layered 
on Ficoll-Paque Plus (Amersham Biosciences, USA) 
the ratio of 2:1. The mixture was centrifuged at 400 
x g for 40 minutes at 18-20oC. The undisturbed 
lymphocyte layer was carefully transferred out. The 
lymphocyte was washed and pelleted down with 
three volume of Phosphate buffer saline (PBS) for 
twice and resuspended in DMEM media (Flowlab, 
Australia) with 100 IU/mL of penicillin, 100 µg/mL 
of streptomycin (Flowlab, Australia), 10% v/v Fetal 
Bovine Serum (FBS) (PAA, Austria). Cell counting 
was performed to determine the PBMC cell number 
in equal volume of trypan blue. PBMC was used as a 
normal positive.
Compounds
The damnacanthal and nordamnacanthal which 
were kindly supplied by Prof. Nordin Haji Lajis from 
Institute of Bioscience were isolated from the roots of 
Morinda elliptica (Ismail et al., 1997). The zerumbone 
which was isolated from the rhizome of Zingiber 
zerumbet was obtained from Prof. Dr. Hasnah Siraj, 
Universiti Teknology Malaysia (UTM). Betulinic 
acid which was extracted from the bark of Melaleuca 
cajuputi was kindly supplied by Associate Prof. 
Dr. Faujan Ahmad, from Department of Chemistry, 
Faculty of Science, Universiti Putra Malaysia. All the 
compounds were isolated from the natural resources 
as stated above. The powdered-form compounds 
(damnacanthal, nordamnacanthal, zerumbone and 
betulinic acid) were dissolved in dimethylsulphoxide 
(DMSO) (Sigma, USA) to get a stock solution of 10 
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mg/mL. The substock solution of 0.06 mg/mL was 
prepared by diluting 6 µl of the stock solution into 
994 µL serum-free culture medium, RPMI 1640 
(the percentage of DMSO in the experiment should 
not exceed 0.5). The stock and substock solutions 
were both stored at 40C. Doxorubicin was used as a 
positive control. This commercial drug was prepared 
by dissolving it with RPMI medium. The stock and 
substock solutions were prepared as above.
Cytotoxicity Assay
Varying concentrations of 0.46, 0.93, 1.87, 
3.75, 7.5, 15 and 30 µg/mL of damnacanthal, 
nordamnacanthal, zerumbone and betulinic acid 
were prepared from the substock solutions by serial 
dilution in RPMI-1640 to give a volume of 100 µL 
in each microtitre plate well. Each well was then 
added with 100 µL of cell lines in complete growth 
media (RPMI 1640) 5 X 105 cells/mL. Controls 
that contained only the cells were also prepared for 
each sample. The assay for each concentration of 
compounds was performed in triplicate. The plate 
was then incubated at 370C, 5% CO2, 90% humidity 
for 72 h. Cytotoxicity of the tested compounds was 
measured using a modified MTT assay (Sigma, USA) 
(Mosmann, 1983). MTT was dissolved in phosphate 
buffer saline (PBS) (pH 7.5) at 5 mg/mL. The MTT 
stock solution was added directly to all appropriate 
microtitre-plate wells (20 µL for each well). The plate 
was then incubated for 2 to 4 h at 370C and 5% CO2. 
After incubation, MTT were reduced to insoluble 
purple formazan crystals by metabolically active 
cells in the wells. Subsequently, the supernatant was 
aspirated and 100 µL of Dimethylsulfoxide (Sigma, 
USA) was added and mix thoroughly to dissolve the 
dark blue formazan crystals. The optical density (OD) 
was measured on an automated spectrophotometric 
EL 340 multiplate/microelisa reader (Bio-Tek 
instruments Inc) using test and reference wavelength 
of 570 nm. The cytotoxic dose that kills cells by 
50% (IC50) was determined from absorbance versus 
concentration curve.
Flow Cytometer Analyses 
Flow cytometer was used to support the 
cytotoxicity results of the cancer cells and the 
proliferation of human PBMC in the MTT assay. 
For cytotoxicity study, HL-60 was chosen since 
that most of the compounds in this study exhibited 
stronger inhibition with the IC50 value less than 5 µg/
mL. Nordamnacanthal however was not tested by 
cell cycle analysis due to the higher IC50 value (23.3 
µg/mL) for cytotoxic effect as well as the source 
of nordamnacanthal was also limited. The HL-60 
was treated for 24, 48 and 72 h with damnacanthal, 
betulinic acid, zerumbone and doxorubicin at their 
respective IC50 value. 
In this study, 1 mL of HL-60 cells with a density 
1 x 106 cells/mL, respectively were treated with 1 
mL of damnacanthal, betulinic acid, zerumbone, 
doxorubicin and PWM according to their IC50 value 
(for cytotoxicity study). The treatment was carried 
out in the 6 well plates (Nunc) with the total working 
volume of 2 mL for each well. The treated cells were 
than incubated for 24, 48 and 72 h and harvested 
by centrifugation at 1000 rpm (200 x g) for 10 min. 
Subsequently, the treated cells were fixed with 80% 
ethanol at 4oC for 2 h. Then, the cells were spun 
down and washed twice with PBS pH 7.5. The cell 
pellets were finally dissolved and stained in PBS 
buffer consist of 0.1% triton X-100, 10 mM EDTA, 
50 µg/mL RNase and 3 µg/mL propidium iodide (PI). 
The cell was then incubated for 30 min in 4oC and 
analyzed using the COULTER EPICS ALTRA flow 
cytometer (Beckman Coulter, USA) at the Laboratory 
of Biologic, Faculty of Veterinary Medicine, UPM 
within 24 h.
Statistical analysis
All experiments were performed in triplicate and 
the results were expressed as mean ± S.E.
Results
Cytotoxicities of pure compounds
The results of cytotoxicities of compounds on 
leukaemia cell lines and normal cells are shown in 
Table 1. Damnacanthal was found to inhibit most 
leukemia cell lines tested with the IC50 value less 
than 10 µg/mL. Damnacanthal was showed stronger 
inhibition towards WEHI-3B and HL-60 with the 
IC50 value of 3.3 ± 0.5 µg/mL and 4.2 ± 0.1 µg/mL, 
respectively and it showed moderate effect towards 
CEM-SS with the IC50 value of 8.5 ± 0.5 µg/mL. 
More interestingly, it showed less effect towards 
3T3 and PBMC with the IC50 value more than 30 
µg/mL. Although nordamnacanthal share the same 
derivatives with damnacanthal, it exhibited variable 
effects towards leukemia cell lines. Nordamnacanthal 
only showed stronger inhibition towards CEM-SS 
with the IC50 value of 5.7 ± 0.4 µg/mL and exhibited 
less toxicity effect towards HL-60 cells with the IC50 
value of 23.3 ± 0.7 µg/mL. In addition, it did not 
affect WEHI-3B, PBMC and 3T3 cells. 
Betulinic acid, exhibited stronger inhibition 
towards HL-60 and WEHI-3B with the IC50 value of 
4.5 ± 0.6 µg/mL and 10.0 ± 0.7 µg/mL, respectively. 
It also demonstrated less effect towards CEM-SS 
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with the IC50 value of 20.5 ± 0.8 µg/mL. Similar to 
damnacanthal and nordamnacanthal, it also did not 
inhibit 3T3 and PBMC. In contrast, zerumbone was 
found to inhibit 3T3 cell at concentration of 30 µg/
mL. Nonetheless, this toxicity effect is considered 
low as suggested by Shier (1991). According to Shier 
(1991), compounds which demonstrated the IC50 
value of more than 10-25 µg/mL will be considered 
weak cytotoxicity while compounds with the IC50 
value of less than 5.0 µg/mL were considered very 
active. Those compounds having intermediate value 
5.0-10.0 µg/mL were classified as moderately active. 
Interestingly, zerumbone showed stronger inhibition 
towards the leukemia cell lines with the IC50 value 
less than 8 µg/mL. It was most toxic towards CEM-
SS with the IC50 value of 1.6 ± 0.8 µg/mL, followed 
by WEHI-3B and HL-60 with the IC50 value of 4.4 ± 
0.2 µg/mL and 7.4 ± 0.8 µg/mL, respectively. 
As compared to all of the natural isolated 
compounds in this study, doxorubicin which is the 
drug for chemotherapy possessed strong cytotoxicity 
against HL-60, CEM-SS and Wehi-3B with IC50 
lower than 5 µg/mL (Table 1). However, unlike all 
of the natural isolated compounds which did not 
show any IC50 at the range of the concentration in 
this study, doxorubicin exhibited strong cytotoxicity 
against mice fibroblast 3T3 (IC50 3 µg/mL) and 
human PBMC (IC50 28 µg/mL).    
Cell Cycle Analysis of Damnacanthal, Betulinic 
Acid, Zerumbone and Doxorubicin on HL-60 Cell 
The changes in the cell cycle distribution of 
HL-60 cells after been treated for 24, 48 and 72 
h with damnacanthal, betulinic acid, zerumbone 
and doxorubicin at their respective IC50 value are 
illustrated in Table 2. 
Analysis of the cell cycle profile showed there 
was an increase in Sub G1 cell population in HL-
60 cells treated with damnacanthal after 24 h (Table 
2). In addition, longer exposure time has lead to an 
additional increase in the percentage of Sub G1 cells 
with value of 1.73% after 24 h up to 25% after 72 
h treatment, respectively. Data also showed that the 
percentage of cells at G2/M phases were decreased 
steadily from 32 % (control) down to 16.95% after 72 
h treatment, suggesting that damnacanthal inhibited 
the progression of HL-60 cells after been treated 
for longer incubation periods. Among the three 
compounds tested, damnacanthal induced a higher 
percentage of apoptosis on HL-60 with value almost 
25%.
On the other hand, HL-60 treated with 4.5 µg/
mL of betulinic acid exhibited a slight increase in 
Sub G1 phase cells after been treated from 24 to 72 h 
with value of 1.07% up to 8.41%, respectively (Table 
2). This data indicated that betulinic acid induced 
a low production of apoptosis rate if compared to 
damnacanthal. HL-60 treated with betulinic acid 
also showed a reduction in S phase cell population 
when induction time was persisted from 24, to 72 h 
with value of 21.7% reduced to 17.34%, respectively. 
Data also designated that betulinic acid arrested HL-
60 cells at G0/G1 phase of the cell cycle with value 
of 63.18%, 67.14% and 64.45% after been treated for 
24, 48 and 72 h. Apart from that, betulinic acid also 
showed to inhibit the progression of HL-60 cells by 
reducing the percentage of cells at G2/M phase from 
32% (control) down to 6.33% after 72 h treatment, 
                   Cell Line
Compounds
IC50 value (µg/mL)
HL-60 CEM-SS WEHI-3B PBMC 3T3
Damnacanthal 4.2 ± 0.1 8.5 ± 0.5 3.3 ± 0.5 > 30 > 30
Nordamnacanthal 23.3 ± 0.7 5.7 ± 0.4 > 30 > 30 > 30
Zerumbone 7.4 ± 0.8 1.6 ± 0.8 4.8 ± 0.2 > 30 30.0
Betulinic acid 4.5 ± 0.6 20.5 ± 0.8 10.0 ± 0.7 > 30 > 30
Doxorubicin 1.2 ± 0.1 2.6 ± 0.2 1.0 ± 0.9 28.0 ± 0.1 3.0 ± 0.8
Table 1. Effects of damnacanthal, nordamnacanthal, betulinic acid, zerumbone towards several 
leukemia cell lines and normal cell at their respective IC50. Data represent means ± SD of triplicate 
determinations from three independent experiments.   
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Compounds Percentage of cell cycle distribution (%)
Incubation period (h)
24 48 72 
 Untreated cell
Sub-G1 (apoptosis)
G0/G1
Synthesis
G2/Mitosis
1.06 ± 0.02
47.35 ± 0.82
17.74 ± 0.31
31.61 ± 0.55
1.51 ± 0.42
46.87 ± 1.35
21.04 ± 0.60
27.90 ± 0.80
1.14 ± 0.70
16.63 ± 0.91
55.64 ± 0.31
28.09 ± 0.16
 Damnacanthal
Sub-G1 (apoptosis)
G0/G1
Synthesis
G2/Mitosis
2.14 ± 0.72
39.52 ± 0.69
27.44 ± 0.70
30.58 ± 0.90
6.24 ± 0.21
13.96 ± 0.42
67.32 ± 0.20
12.34 ± 0.20
24.99 ± 0.56
15.18 ± 0.35
43.37 ± 0.91
16.95 ± 0.35
Betulinic acid
Sub-G1 (apoptosis)
G0/G1
Synthesis
G2/Mitosis
2.14 ± 0.76
61.97 ± 1.59
23.56 ± 3.34
11.44 ± 1.80
3.72 ± 0.89
64.50 ± 3.48
17.55 ± 1.96
10.35 ± 5.04
8.33 ± 0.27
61.55 ± 4.57
16.24 ± 1.78
9.85 ± 3.82
Zerumbone
Sub-G1 (apoptosis)
G0/G1
Synthesis
G2/Mitosis
2.43 ± 0.37
63.75 ± 1.37
19.22 ± 0.88
12.38 ± 2.92
4.35 ± 0.06
67.48 ± 0.82
17.35 ± 0.85
15.68 ± 2.76
4.81 ± 0.08
68.51 ± 0.82
16.71 ± 1.08
14.71 ± 1.32
Doxorubicin
Sub-G1 (apoptosis)
G0/G1
Synthesis
G2/Mitosis
6.35 ± 0.01
52.04 ± 0.12
22.25 ± 0.09
20.95 ± 0.04
17.2 ± 0.04
24.81 ± 0.06
37.86 ± 0.11
15.49 ± 0.04
59.59 ± 0.77
17.15 ± 0.47
10.96 ± 13.86
6.53 ± 0.70
various leukemia cell lines. Damnacanthal and 
nordamnacanthal were also possessed cytotoxicity 
towards human small cell lung cancer (NCI-H187), 
human breast cancer (BC and MCF-7) and Epstein 
Barr Virus in Raji cell (Ali et al., 2000; Jasril et al., 
2003; Kwanjai et al., 2005) . These results suggested 
that damnacanthal and nordamnacanthal have broad 
cytotoxicity towards various cancer cell lines whilst 
damnacanthal was found to be more toxic towards 
HL-60, CEM-SS and WEHI-3B as compared to, 
nordamnacanthal in this study (Table 1). 
Zerumbone is a natural cyclic sesquiterpene 
moiety that can be found abundantly in rhizome of the 
wild ginger, Zingiber zerumbet Smith (Lechat-Vahirua 
et al., 1993; Murakami et al., 1999). It is known to 
have a powerful tool in the implementation of green 
chemistry with latent reactivity which contains three 
double bonds, two conjugated and one isolated as 
well as a double conjugated carbonyl group in 11-
membered ring structure (Kitayama et al., 2006). 
Zerumbone has been identified as a distinct suppressor 
of tumor promoter 12-O-tetradeconoylphorbol-13-
acetate (TPA)-induced Epstein-Barr virus (EBV) 
activation in Raji cells, inhibitor of free radical 
generation, iNOS expression and TNF-α release, 
inhibitor of various human colonic adenocarcinoma 
cell lines proliferation  (L8174, LS180, COLO205 
and COLO320DM) with little effects on the growth 
of normal dermal and colon fibroblast (Murakami 
et al, 1999; 2002; 2004) and suppressor of human 
cancer cells growth via the induction of apoptosis 
(Kirana et al., 2003). 
In this study, zerumbone showed stronger 
cytotoxic effects towards CEM-SS, HL-60 and 
WEHI-3B. The variable cytotoxic effects of 
zerumbone towards those cells are due to its versatile 
chemical structure of α-β-unsaturated carbonyl group. 
This specific group in zerumbone had been shown 
to play the pivotal roles in its interaction with the 
most biological molecules (Murakami et al., 2002). 
Murakami et al. (2002) discovered that α-humulene 
which lacked the functional group (α-β-unsaturated 
carbonyl group), was virtually and consistently 
inactive towards various pharmalogical activities. 
Table 2. Cell cycle distribution of HL-60 cells after been treated at 24, 48 and 72 h with 
damnacanthal, betulinic acid, zerumbone and doxorubicin at their respective IC50 value. Data 
represent means ± SD of triplicate determinations from three independent experiments. 
716 Alitheen, N.B., Mashitoh, A.R., Yeap, S.K., Shuhaimi, M., Abdul Manaf, A. and Nordin, L.
International Food Research Journal 17: 711-719
indicating that it has anti-proliferative effect towards 
HL-60 cells.
HL-60 cultivated with 4.4 µg/mL zerumbone 
showed a slight increase in Sub G1 after been treated 
for 48 h with value of 4.36% (Table 2). However, this 
percentage remained constant until 72 h treatment 
indicating that zerumbone only induced low apoptosis 
rate in HL-60 cells throughout the treatment duration. 
A steady production of Sub G1 cell population after 
been treated for 48 h corresponded to an increase 
in cells population arrested at G0/G1 with almost 
69.93% cells at this phase after 72 h treatment. On the 
other hand, data also demonstrated that the percentage 
of HL-60 cells treated with zerumbone reduced 
dramatically from 32% (control) down to 15.58% 
after been treated for 72 h, leading to inhibition of 
cell division. This data suggesting that zerumbone 
might have anti-proliferative effects towards HL-60 
cells. 
When compared to all of the isolated natural 
compounds, doxorubicin showed the best effect to 
induce apoptosis on HL-60 in the time dependent 
manner. The percentage of sub-G1 increased gradually 
from 24 h (6.35 ± 0.01%) to 72 h (59.59 ± 0.77%).  
Discussion
Damnacanthal and nordamnacanthal are 
anthraquinones produced mainly by plant of the 
Rubiaceae family. Both compounds were commonly 
isolated from Morinda citrofolia, Morinda elliptica, 
Morinda lucida and Prismatomeris fragrans (Ismail 
et al., 1997; Tosa et al., 1998; Kwanjai et al., 2005). 
Damnacanthal and nordamnacanthal were known 
to possess some unique chemical and biological 
properties. 
Apparently, both compounds showed toxicity 
effect towards leukemia cell lines which are 
categorized as anchorage-independent cell lines. 
Previously, Ali et al. (2000) reported that both 
compounds damnacanthal and nordamnacanthal 
exhibited to be more sensitive towards the anchorage-
independent cell lines. This is due to the anchorage-
dependent cell lines require attachment to a solid 
matrix which create cell to cell contact. This interaction 
generates transmembrane signal that affected the cell 
proliferation, migration, differentiation and survival 
of the cell from undergoing apoptosis. The importance 
of attachment of anchorage-dependent cell line was 
supported by Singh et al. (1996) which revealed that 
primary culture that require anchorage will undergo 
apoptosis in suspension culture. Thus, this has proven 
that anchorage-independent cell lines have undergone 
genetic changes through transformation that prevent 
expression of the apoptotic pathway in response to 
the lost of contact which caused them to be more 
sensitive towards cytotoxic drug and chemical. 
 Even though the chemical structure between 
damnacanthal and nordamnacanthal was closely 
related, there was a significant difference on the 
cytotoxicity effect towards several leukemia cell 
lines. This is due to the existence of methoxyl group 
(-OCH3) of damnacanthal at position C-1 whilst 
nordamnacanthal had hydroxyl group (-OH) at the 
same position. The existence of this different group is 
predicted to be the contributing factor to the variable 
effects of damnacanthal and nordamnacanthal 
towards cancerous cell lines. According to Ali 
et al. (2000), the presence of hydroxyl group at 
C-1 and C-3 and/ or a formyl group at C-2 in the 
anthraquinone skeleton, such as nordamnacanthal 
and rubiacin may exert their cytotoxicity effects 
towards several cancerous cell lines. Nevertheless, 
Kamei et al. (1998) reported that anthraquinones 
with more hydroxyl groups were more effective 
than those with less or without the existence of the 
group, thus suggesting that nordamnacanthal was 
more active compared to damnacanthal in inhibiting 
cancer cells. However, current result demonstrated 
that damnacanthal was more toxic towards those 
leukemia cell lines with the IC50 value less than 10 
µg/mL. This result is in accordance with previous 
finding by Konoshima et al. (1989). The group has 
discovered that not only the number but the position 
of hydroxyl groups would influence the activity of 
an anthraquinone, hence suporting that damnacanthal 
was more active compared to nordamnacanthal. 
Furthermore, Rajendran et al. (2004) showed that 
the existence of methoxyl group (-OCH3) at C-1 
position of damnacanthal is expected to show higher 
efficiencies for generation of singlet oxygen (1O2) and 
superoxide anion radical (O2
•–) than nordamnacanthal, 
thus supporting the capability of damnacanthal 
to be more toxic towards those leukemia cell lines 
compared to nordamnacanthal. Damnacanthal has 
also possesed high ability to generate reactive oxygen 
species compared to nordamnacanthal (Rajendran et 
al., 2004). Hence it has the capability to neutralize 
the toxicity of ROS which caused lipid peroxidation, 
protein oxidation and most importantly DNA damage 
(Flora and Ferguson, 2005). DNA damage can result 
in base mutation, single or double strand break, 
DNA cross-linking and chromosomal abnormalities 
(Issa et al., 2006). Irreversible DNA damage is 
recognized as an early step in the initiation of the 
carcinogenesis process. Therefore, damnacanthal 
which has methoxyl group (-OCH3) at C-1 position 
might prevent carcinogenesis process and inhibiting 
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In addition, the chemical property of zerumbone to 
conjugate biological nucleophiles may be essential 
for exerting its activity. Nakamura et al. (2004) 
recently discovered that the α-β-unsaturated carbonyl 
in zerumbone has made it more electrophilic as 
compared to the non-electrophilicity of α-humulene 
and 8-OH-humulene. This electrophilic property 
enables zerumbone to react with biological 
nucleophiles, such as ІқB protein by modifying the 
cysteine residue thus attenuating ІқB phosphorylation 
to abolish the NF-қB activity (Murakami et al., 2002). 
This structure- activity relationship has also been 
found in some physiological activities, including 
suppressor of Epstein-Barr virus activation in Raji 
cells and inhibition of O2
- generation of differentiated 
HL-60 cells (Murakami et al., 2002). Moreover, this 
property provides biological evidence of its role as an 
antioxidant in activating the detoxification enzyme 
system as well as neutralizing the lipid peroxidation 
in hepatocytes, which also could affect its cytotoxic 
towards cancer cells (Nakamura et al., 2004).  
Betulinic acid, a plant-derived pentacyclic lupine 
type triterpene, has been recognized to possess 
potent pharmalogical properties. Current study 
demonstrated that betulinic acid had strong cytotoxic 
effects towards HL-60 and WEHI-3B but less toxicity 
towards CEM-SS. This result supported the report of 
it’s cytotoxicity towards various leukemia cells. In 
previous reports, Ehrhardt et al. (2004) discovered 
that betulinic acid induced apoptosis in hematological 
malignancies where 65% of primary pediatric acute 
leukemia and all cell lines of these types were 
sensitive to betulinic acid in vitro. Poon et al. (2004) 
also reported that betulinic acid was cytotoxic and 
enhanced 1[alpha],25-dihydroxyvitamin D3-induced 
differentiation in human HL-60 promyelocytic 
leukemia cells. Sensitivity of betulinic acid towards 
cancerous cells was not only limited towards 
leukemia cells as it was known to be cytotoxic 
towards various cancerous cells. Research done 
by Pisha et al. (1995) exhibited that betulinic acid 
induced melanoma specific cytotoxic towards 
athymic mice and human melanoma xenografts by 
regressing more than 80% tumor growth. Fulda et 
al. (1998) reported betulinic acid induced apoptosis 
in neuroblastoma, medullablastoma and Ewing’s 
sarcoma cell lines, which are the most common solid 
tumors in childhood. Subsequently, betulinic acid 
also showed to be cytotoxic towards primary tumor 
cell culture from medullablastoma and glioblastoma 
(Fulda et al., 1999), glioma cell lines as wells as 
head and neck squamous cellular carcinoma cell 
lines (Thurnher et al., 2003). Recently, betulinic acid 
was reported to be strongly cytotoxic and cytostatic 
towards most prevalent human cancer types such as 
lung, colorectal, breast, prostate and cervical cancer 
(Jan et al., 2007).
There are some possible reasons supporting the 
broad toxicity effect of betulinic acid towards various 
cancerous cells. One of them is due to its structure 
activity relationship or known as SAR. According 
to Sami et al. (2006) the hydroxylation at C-3 and 
C-28 position of betulinic acid is likely to enhance its 
cytotoxic effects towards various cancer cells. This 
finding was in an agreement with the finding by Liu 
et al. (2004) that showed the hydroxylation of C-3 
position of betulinic acid is vulnerable to enhance the 
apoptotic activity of betulinic acid and its derivatives 
on murine melanoma B16 cells. In addition, betulinic 
acid which easily can be converted from its structurally 
related precursor, betuline was identified in chemical 
structure as a lipophilic and thus poorly soluble in 
water. Betuline was known to have three positions 
in its structure, namely secondary hydroxyl group 
at position C-3, primary hydroxyl group at position 
C-28 and alkene moiety at position C-20, where 
chemical modifications can be easily performed to 
yield derivatives such as betulinic acid. Some of 
betuline derivatives were commonly in a lipophilic 
structure. This may have a significant role or effects 
towards its cytotoxicity effects on cancer cells (Sami 
et al., 2006), thus supporting this present results on 
the cytoxic effects of betulinic acid towards HL-60, 
WEHI-3B and CEM-SS cells leukemia.        
Cancers and many human diseases have been 
known as cell cycle diseases (Liu et al., 2004). This 
is due to common alteration and many regulatory 
factors of checkpoints are lost or arrested during 
the process of tumorigenesis. However, there are 
several chemopreventive phytochemicals such 
as curcumin and catechin could restore and alter 
regulatory checkpoints through inducing apoptosis 
and cell cycle arrest (Liu et al., 2004). Therefore, cell 
cycle analysis has been carried out to evaluate the 
effect of damnacanthal, betulinic acid, zerumbone 
and doxorubicin on HL-60 cells. Cell cycle analysis 
revealed HL-60 treated with betulinic acid has 
induced apoptosis and cell cycle arrest at G0/G1. 
After 72 h, approximately 8.41% of viable cells 
were in the sub G1, indicating the apoptotic phase. 
This finding was similar with finding by Poon et 
al. (2004). They reported that betulinic acid was 
cytotoxic towards HL-60 cells IC50 value = 5.7 µM) 
and induced apoptosis in cell cycle analysis with 
approximately 10% of viable cells were in the sub G1 
phase after exposure of the cells to 12 µM of betulinic 
acid. However, the apoptosis rate of betulinic acid 
towards HL-60 is considered low when compared 
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to its derivatives 23-hydroxybetulinic acid. Ji et al. 
(2002) discovered that 23-hydroxybetulinic acid 
induced apoptosis in HL-60 cells with approximately 
46.61% cells were in sub G1 after exposure of cells 
to 10 µM for 24 h. Subsequently, the apoptotic events 
in their experiment were associated with concurrent 
down-regulation of Bcl-2 and the telomerase activity 
(Ji et al., 2002). 
Conclusion
This current study has effectively demonstrated 
that those compounds have a good potential anti 
cancer drug that may lack toxic effects towards 
healthy tissue and immune system. Damnacanthal, 
nordamnacanthal and betulinic acid have successfully 
exhibited to be cytotoxic towards various leukemia 
cell lines without causing toxicity towards normal 
cell 3T3. Further in vitro study on the compounds 
involving their pharmacokinetics and toxicology 
effects should be carried out before undergoing with 
in vivo or clinical works. 
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